Soy and bone: Where do we stand?

Orthopaedic Nursing

Volumn 23, Issue 1, 2004, Pages 12-17

  Harkness, Laura ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Bone loss; Nutrition; Soy

Indexed keywords

ISOFLAVONE DERIVATIVE;

ANIMAL; BONE; DRUG EFFECT; FEMALE; HUMAN; PATHOPHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; RAT; REVIEW; SOYBEAN; UNITED STATES;

ANIMALS; BONE AND BONES; FEMALE; HUMANS; ISOFLAVONES; OSTEOPOROSIS, POSTMENOPAUSAL; RATS; SOY FOODS; UNITED STATES;

EID: 1642263158     PISSN: 07446020     EISSN: 1542538X     Source Type: Journal    
DOI: 10.1097/00006416-200401000-00006     Document Type: Article

References (57)

1. Alekel, D. L., St. Germain, A., Peterson, C. T., Hanson, K. B., Stewart, J. W., Toda, T. (2000). Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. American Journal of Clinical Nutrition, 72( 3), 844-852.
2. Anderson, J. J., Ambrose, W. W., Garner, S. C. (1998). Biphasic effects of genistein on bone tissue in the ovariectomized lactating rat model. Proceedings of the Society for Experimental Biology and Medicine, 217( 3), 345-350.
3. Arjmandi, B. H., Alekel, L., Hollis, B., Amin, D., Stacewicz-Sapuntzakis, M., Guo, P., et al. (1996). Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. Journal of Nutrition, 126( 1), 161-167.
4. Bason, W. (1996). Secular trends in hip fracture occurrence and survival: Age and sex differences. Journal of Aging and Health, 8( 4), 538-553.
5. Benvenuti, S., Tanini, A., Frediani, U., et al. (1991). Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line. Journal of Bone and Mineral Research, 6( 9),987-996.
6. Black, D., Cummings, S., Genant, H., Nevitt, M., Palermo, L., Browner, W. (1992). Axial and appendicular bone density predict fractures in older women. Journal of Bone and Mineral Research, 7( 6),633-638.
7. Brown, J. P., Delmas, P. D., Arlot, M., Meunier, P. J. (1987). Active bone turnover of the cortico-endosteal envelope in postmenopausal osteoporosis. Journal of Clinical Endocrinology and Metabolism, 64( 5), 954-959.
8. Brown, J. P., Malaval, L., Chapuy, M. C., Delmas, P. D., Edouard, C., Meunier, P. J. (1984) Serum bone GLA-protein: A specific marker for bone formation in postmenopausal osteoporosis. Lancet, 1( 8386), 1091-1093.
9. Cassidy, A., Bingham, S., Setchell, K. D. R. (1994). Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. American Journal of Clinical Nutrition, 60( 3), 333-340.
10. Centers for Disease Control (CDC). (1998). Osteoporosis among estrogen deficient women—United States, 1988-1994. MMWR Morbidity and Mortality Weekly Report, 47( 45), 969-973.
11. Chesnut, C. (1991). Theoretical overview: Bone development, peak bone mass, bone loss, and fracture risk. American Journal of Medicine, 91( 5B), 2S-4S.
12. Coward, L., Barnes, N. C., Setchell, K. D. R., Barnes, S. (1993). Genistein, daidzein, and their beta-glycoside conjugates: Antitumor isoflavones in soybean foods from American and Asian diets. Journal of Agriculture and Food Chemistry, 41( 11), 1961-1967.
13. Draper, C. R., Edel, M. J., Dick, I. M., Randall, A. G., Martin, G. B., Prince, R. L. (1997). Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. Journal of Nutrition, 127( 9), 1795-1799.
14. Eriksen, E., Colvard, D., Berg, N., Graham, M. L., Mannet, K. G., Spelsberg, T. C., et al. (1988). Evidence of estrogen receptors in normal human osteoblast-like cells. Science, 241( 4861),84-86.
15. Ettinger, B., Genant, H., Cann, C. (1985). Long-term estrogen replacement therapy prevents bone loss and fractures. Annals of Internal Medicine, 102( 3), 319-324.
16. Farnsworth, N. R., Bingel, A. S., Cordell, G. A., Crane, F. A., Fond, H. H. S. (1975). Potential value of plants as sources of new antifertility agents. Journal of Pharmacological Sciences, 64( 4), 535-598.
17. Gallagher, J. C., Goldgar, D., Moy, A. (1987). Total bone calcium in normal women: Effect of age and menopause status. Journal of Bone and Mineral Research, 6( 2), 491-496.
18. Garnero, P., Sornay-Rendu, E., Chapuy, M. C., Delmas, P. D. (1996). Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. Journal of Bone and Mineral Research, 11( 3), 337-349.
19. Greendale, G. A., FitzGerald, G., Huang, M., Sternfeld, B., Gold, E., Seeman, T., et al. (2002). Dietary soy isoflavones and bone mineral density: Results from the Study of Women’s Health Across the Nation. American Journal of Epidemiology, 155( 8), 746-753.
20. Harris, S., Dawson-Hughes, B. (1992). Rates of changes in bone mineral density of the spine, heel, femoral neck, and radius in healthy postmenopausal women. Bone and Mineral, 17( 1), 87-95.
21. Horiuchi, T., Onouchi, T., Takahashi, M., Ito, H., Orimo, H. (2000). Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteoporosis International, 11( 8), 721-724.
22. Johannes, C., Crawford, S., Posner, J., McKinley, S. (1994). Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. American Journal of Epidemiology, 140( 5), 439-452.
23. Kanis, J. (1991). The restoration of skeletal mass: A theoretical overview. American Journal of Medicine, 91( 5B), 29S-35S.
24. Knight, D. C., Eden, J. A. (1996). A review of the clinical effects of phytoestrogens. Obstetrics and Gynecology, 87( 5), 897-904.
25. Kurzer, M. S., Xu, X. (1997). Dietary phytoestrogens. Annual Review of Nutrition, 17, 353-381.
26. Lauderdale, D., Jacobsen, S., Furner, S., Levy, P., Brody, J., Goldberg, J., et al. (1997). Hip fracture incidence among elderly Asian-American populations. American Journal of Epidemiology, 146( 6), 502-509.
27. Leiberman, S. (1996). Are the differences between estradiol and other estrogens, naturally occurring or synthetic, merely semantical? Journal of Clinical Endocrinology and Metabolism, 81( 2), 850-851.
28. Looker, A., Johnston, C., Wahner, H., Dunn, W., Calvo, M., Harris, T., et al. (1995). Prevalence of low femoral bone density in older US women from NHANES III. Journal of Bone and Mineral Research, 10( 5), 796-802.
29. Lu, L. J., Anderson, K. E., Grady, L. L., Nagamani, M. (1996). Effects of soy consumption for one month on steroid hormones in premenopausal women: Implications for breast cancer risk reduction. Cancer Epidemiology, Biomarkers and Prevention, 5( 1), 63-70.
30. Matkovic, V., Fontana, D., Tominac, C. (1990). Factors that influence peak bone formation: A study of calcium balance and the inheritance of bone mass in adolescent females. American Journal of Clinical Nutrition, 52( 5), 878-888.
31. Melton III, L. J., Khosia, S., Atkinson, E. J., O’Fallon, W. M., Riggs, B. L. (1997). Relationship of bone turnover to bone density and fractures. Journal of Bone and Mineral Research, 12( 7), 1083-1091.
32. Nagata, C., Shimizu, H., Takami, R., Hayashi, M., Takeda, N., Yasuda, K. (2002). Soy product intake and serum isoflavonoid and estradiol concentrations in relation to bone mineral density in postmenopausal Japanese women. Osteoporosis International, 13( 3), 200-204.
33. National Institutes of Health Osteoporosis and Related Bone Diseases—National Resource Center (NIH). (2002). Fast facts on osteoporosis. Retrieved October, 10, 2002, from .
34. Nikov, G., Hopkins, N., Boue, S., Alworth, W. (2000). Interactions of dietary estrogens with human estrogen receptors and the effect on estrogen receptor-estrogen response element complex formation. Environmental Health Perspectives, 108( 9), 867-872.
35. Okano, H., Mizunuma, H., Soda, M., Kagami, I., Miyamoto, S., Ohsawa, M., et al. (1998). The long-term effect of menopause on postmenopausal bone loss in Japanese women: Results of a prospective study. Journal of Bone and Mineral Research, 13( 2), 303-309.
36. Omi, N., Aoi, S., Murata, K., Ezawa, I. (1994) Evaluation of the effect of soybean milk and soybean milk peptide on bone metabolism in the rat model with ovariectomized osteoporosis. Journal of Nutritional Science and Vitaminology, 40( 2), 201-211.
37. Oursler, M., Landers, J., Riggs, B., Splesberg, T. (1993). Oestrogen effects on osteoblasts and osteoclasts. Annals of Medicine, 25( 4), 361-371.
38. Picherit, C., Bennetau-Pelissero, C., Chanteranne, B., Lebeque, P., Davicco, M. J., Barlet, J. P., et al. (2001). Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. Journal of Nutrition, 131( 3), 723-728.
39. Podenphant, J., Johansen, J. S., Thomsen, K., Riis, B. J., Leth, A., Christiansen, C. (1987). Bone turnover in spinal osteoporosis. Journal of Bone and Mineral Research, 2( 6), 497-502.
40. Popock, N., Eisman, J., Hopper, J. (1987). Genetic determinants of bone mass in adults. A twin study. Journal of Clinical Investigation, 80( 3), 706-710.
41. Potter, S. M., Baum, J. A., Teng, H., Stillman, R. J., Shay, N. F., Erdman, J. W. (1998). Soy protein and isoflavones: Their effects on blood lipids and bone density in post-menopausal women. American Journal of Clinical Nutrition, 68(6S), 1375S-1379S.
42. Pouilles, J., Tremollieres, F., Ribot, C. (1993). The effects of menopause on longitudinal bone loss from the spine. Calcified Tissue International, 52( 5), 340-343.
43. Prestwood, K., Pilbeam, C., Burleson, J., Woodiel, F., Delmas, P. D., Deftos, L. J., et al. (1994). The short-term effects of conjugated estrogen on bone turnover in older women. Journal of Clinical Endocrinology and Metabolism, 79( 2), 366-371.
44. Price, K. R., Fenwick, G. R. (1985). Naturally occurring oestrogens in foods—a review. Food Additives and Contaminants, 2( 2), 73-106.
45. Ravn, P., Fledelius, C., Rosenquist, C., Overgaard, K., Christiansen, C. (1996). High bone turnover is associated with low bone mass in both pre- and postmenopausal women. Bone, 19( 3), 291-298.
46. Riggs, B., Melton, L. (1995). The worldwide problem of osteoporosis: Insights afforded by epidemiology. Bone, 17( 5), 505S-511S.
47. Riggs, B., Walmer, H., Seeman, E. (1982). Changes in bone mineral density of the proximal femur and spine with aging. Journal of Clinical Investigation, 70( 4), 716-723.
48. Ross, P. D., Knowlton, W. (1998). Rapid bone loss is associated with increased levels of biochemical markers. Journal of Bone and Mineral Research, 13( 2), 297-302.
49. Silverman, S. L., Madison, R. E. (1988). Decreased incidence of hip fracture in Hispanics, Asians, and Blacks: California hospital discharge data. American Journal of Public Health, 78( 11), 1482-1483.
50. Somekawa, Y., Chiguchi, M., I shibashi, T., Aso, T. (2001). Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstetrics and Gynecology, 97( 1), 109-115.
51. United Soybean Board (USB). (2002). National Report: Consumer attitudes about nutrition. Retrieved October 28, 2002, from .
52. Wang, H., Murphy, P. A. (1994). Isoflavone content in commercial soybean foods. Journal of Agriculture and Food Chemistry, 42( 8), 1666-1673.
53. Wangen, K. E., Duncan, A. M., Merz-Demlow, B. E., Xu, X., Marcus, R., Phipps, W. R., et al. (2000). Effects of soy isoflavone on markers of bone turnover in premenopausal and postmenopausal women. Journal of Clinical Endocrinology and Metabolism, 85( 9), 3043-3048.
54. Weaver, C. (1994). Age related calcium requirements due to changes in absorption and utilization. Journal of Nutrition, 124( 8), 1418S-125S.
55. Weiss, N., Ure, C., Ballard, J., Williams, A., Daling, J. (1980). Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. New England Journal of Medicine, 303( 21), 1195-1198.
56. World Health Organization (WHO). (1994). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report Series 866. Geneva: World Health Organization.
57. Writing Group for the Women’s Health Initiative Investigators (WHI). (2002). Risks and benefits of estrogen plus progestin in health postmenopausal women. Principal results from the Women’s Health Initiative Randomized Controlled Trial. JAMA, 288( 3), 321-333.